Medifast, Inc. (MED)

Medifast Statistics

Total Valuation

Medifast has a market cap or net worth of $135.69 million. The enterprise value is -$10.99 million.

Market Cap	135.69M
Enterprise Value	-10.99M

Important Dates

The last earnings date was Monday, April 28, 2025, after market close.

Earnings Date	Apr 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Medifast has 10.34 million shares outstanding. The number of shares has increased by 0.04% in one year.

Current Share Class	10.34M
Shares Outstanding	10.34M
Shares Change (YoY)	+0.04%
Shares Change (QoQ)	-0.32%
Owned by Insiders (%)	2.52%
Owned by Institutions (%)	78.33%
Float	9.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.26
Forward PS	0.33
PB Ratio	0.63
P/TBV Ratio	0.66
P/FCF Ratio	10.32
P/OCF Ratio	6.75
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.52, with a Debt / Equity ratio of 0.07.

Current Ratio	3.52
Quick Ratio	2.72
Debt / Equity	0.07
Debt / EBITDA	0.61
Debt / FCF	1.09
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -3.32% and return on invested capital (ROIC) is 1.69%.

Return on Equity (ROE)	-3.32%
Return on Assets (ROA)	1.33%
Return on Invested Capital (ROIC)	1.69%
Return on Capital Employed (ROCE)	2.82%
Revenue Per Employee	$1.08M
Profits Per Employee	-$13,883
Employee Count	504
Asset Turnover	1.87
Inventory Turnover	3.31

Taxes

Income Tax	-275,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.50% in the last 52 weeks. The beta is 0.98, so Medifast's price volatility has been similar to the market average.

Beta (5Y)	0.98
52-Week Price Change	-47.50%
50-Day Moving Average	13.33
200-Day Moving Average	16.84
Relative Strength Index (RSI)	52.67
Average Volume (20 Days)	218,732

Short Selling Information

The latest short interest is 1.15 million, so 11.17% of the outstanding shares have been sold short.

Short Interest	1.15M
Short Previous Month	1.38M
Short % of Shares Out	11.17%
Short % of Float	12.58%
Short Ratio (days to cover)	4.82

Income Statement

In the last 12 months, Medifast had revenue of $543.45 million and -$7.00 million in losses. Loss per share was -$0.64.

Revenue	543.45M
Gross Profit	401.58M
Operating Income	6.18M
Pretax Income	37.29M
Net Income	-7.00M
EBITDA	18.90M
EBIT	6.18M
Loss Per Share	-$0.64

Balance Sheet

The company has $164.59 million in cash and $14.61 million in debt, giving a net cash position of $149.98 million or $14.50 per share.

Cash & Cash Equivalents	164.59M
Total Debt	14.61M
Net Cash	149.98M
Net Cash Per Share	$14.50
Equity (Book Value)	210.96M
Book Value Per Share	20.40
Working Capital	152.93M

Cash Flow

In the last 12 months, operating cash flow was $20.60 million and capital expenditures -$7.14 million, giving a free cash flow of $13.47 million.

Operating Cash Flow	20.60M
Capital Expenditures	-7.14M
Free Cash Flow	13.47M
FCF Per Share	$1.30

Margins

Gross margin is 73.89%, with operating and profit margins of 1.14% and -1.29%.

Gross Margin	73.89%
Operating Margin	1.14%
Pretax Margin	-1.34%
Profit Margin	-1.29%
EBITDA Margin	3.48%
EBIT Margin	1.14%
FCF Margin	2.48%

Dividends & Yields

Medifast does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.04%
Shareholder Yield	-0.04%
Earnings Yield	-5.03%
FCF Yield	9.69%

Analyst Forecast

The average price target for Medifast is $16.50, which is 25.76% higher than the current price. The consensus rating is "Hold".

Price Target	$16.50
Price Target Difference	25.76%
Analyst Consensus	Hold
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medifast has an Altman Z-Score of 5.4 and a Piotroski F-Score of 5.

Altman Z-Score	5.4
Piotroski F-Score	5